EUVIMEDEUVIMED entdecken
Open Access

Breast biomarkers evolution between primary and distant metastasis: incidence and significance

Maha Khedr iD, Shipra Gandhi iD, Arya Mariam Roy iD, Malak Alharbi iD, Anthony George iD, Kristopher Attwood iD, Thaer Khoury iD

Histopathology · 2025

DOI: 10.1111/his.15387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Maha Khedr und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate the evolution when breast cancer (BC) is classified as three clinical profiles and five clinical profiles by incorporating human epidermal growth factor 2 (HER2)‐low to the biomarkers’ profile. Methods and results BC with distant metastasis that has document hormonal receptors (HR) (positive, negative) and HER2 (positive, low, zero) results were included ( n = 161). Cases were categorised into three clinical profiles (HR‐positive/HER2‐negative, HER2‐positive and TNBC) and five (HR‐positive/HER2‐zero, HR‐positive/HER2‐low, HR‐negative/HER2‐zero, HR‐negative/HER2‐low, HR‐positive or negative/HER2‐positive). Evolution occurred in 22.4% cases when three clinical profiles were analysed and 36.6% considering five clinical profiles. There were no statistically significant differences among the three clinical profiles in overall survival (OS). When five clinical profiles were analysed, HR‐negative/HER2‐zero had the worst OS with HzR = 6.82 and 95% confidence interval (CI) =1.19, 39.23, P = 0.031. In the multivariable analysis, ER‐positive was associated with HER2 discordance less than oestrogen receptor (ER)‐negative with odds ratio (OR) = 0.354 and 95% CI = 0.14–0.88, P = 0.025. In the multivariable analysis, patients with Eastern Cooperative Oncology Group 2+ had worse OS with hazard ratio (HzR) = 5.54 and 95% CI = 2.4–12.79, P < 0.0001. HR concordant had better OS with HzR = 0.34 and 95% CI = 0.2–0.63, P = 0.0004. HER2 conversion from low to zero had worse OS than HER2 concordance with HzR 2.66 and 95% CI = 1.21–5.83, P = 0.015.

Conclusions

Five‐profile classification provides a more accurate idea about the rate of potential change in treating BC in the metastatic setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesHumansFemaleMiddle AgedReceptors, EstrogenAdultAgedReceptors, ProgesteroneIncidencePrognosisAged, 80 and overNeoplasm Metastasis

Stichwörter der Autor:innen

HER2‐lowbiomarkersbreast cancerevolutionmetastasisprognosis

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneERBB2 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Department of Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.

ORCID-Profile: Maha Khedr, Shipra Gandhi, Arya Mariam Roy, Malak Alharbi, Anthony George, Kristopher Attwood, Thaer Khoury

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Khedr, M., Gandhi, S., Roy, A. M., Alharbi, M., George, A., Attwood, K., & Khoury, T. (2025). Breast biomarkers evolution between primary and distant metastasis: incidence and significance. Histopathology. https://doi.org/10.1111/his.15387

Vancouver

Khedr M, Gandhi S, Roy AM, Alharbi M, George A, Attwood K, et al. Breast biomarkers evolution between primary and distant metastasis: incidence and significance. Histopathology. 2025. doi:10.1111/his.15387

BibTeX
@article{Khedr2025,
  author = {Khedr, Maha and Gandhi, Shipra and Roy, Arya Mariam and Alharbi, Malak and George, Anthony and Attwood, Kristopher and Khoury, Thaer},
  title = {Breast biomarkers evolution between primary and distant metastasis: incidence and significance},
  journal = {Histopathology},
  year = {2025},
  doi = {10.1111/his.15387}
}
Kostenlos starten →